About Service de néphrologie, CHU de Besançon
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Service de néphrologie, CHU de Besançon
During the past decade, Service de néphrologie, CHU de Besançon conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study Evaluating Prophylaxis Treatment & Characterizing Efficacy, Safety, & PK Of B-Domain Deleted Recombinant FVIII
2007-12-01
2018-04-01
Completed
66
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Lower Risk Myelodysplastic Syndrome (MDS) Without Del 5q
2010-01-26
2018-05-09
Completed
239
LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy
2012-03-05
2017-12-27
Completed
795
Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE)
2013-09-25
2019-11-14
Completed
267
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Safety of Dabigatran Etexilate in Blood Clot Prevention in Children
2014-09-29
2019-11-19
Completed
214
Pembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-05/ECHO-305-05)
2017-12-15
2020-11-09
Completed
154
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Service de néphrologie, CHU de Besançon
According to Clinical.Site data, the most researched conditions in "Service de néphrologie, CHU de Besançon" are
"Anemia" (1 trials), "Chronic Renal Disease" (1 trials), "End Stage Renal Disease on Dialysis" (1 trials), "Peritoneal Dialysis" (1 trials) and "Renal Anemia of Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "Service de néphrologie, CHU de Besançon" in a lesser frequency.
Clinical Trials Intervention Types at Service de néphrologie, CHU de Besançon
Most popular intervention types in "Service de néphrologie, CHU de Besançon" are "Biological" (2 trials), "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Blood sample" (2 trials), "Methoxy Polyethylene Glycol-Epoetin Beta" (1 trials), "Methoxy polyethylene glycol-epoetin beta" (1 trials) and "Questionnaire" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Service de néphrologie, CHU de Besançon
The vast majority of trials in "Service de néphrologie, CHU de Besançon" are
5 trials for "All" genders.
Clinical Trials Status at Service de néphrologie, CHU de Besançon
Currently, there are NaN active trials in "Service de néphrologie, CHU de Besançon".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Service de néphrologie, CHU de Besançon,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Service de néphrologie, CHU de Besançon, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".